Month : June 2025

Business

EU nuclear sector adds €251.2 billion to economy and 883000 jobs

omandailynews.com
The European Union’s nuclear sector currently contributes €251.2 billion annually to the region’s economic output and sustains more than 883,000 jobs, according to a recent report commissioned by Brussels-based industry association Nucleareurope and prepared by Deloitte. The study evaluates both the current and potential future economic impacts of the EU’s nuclear industry as the......
PR Newswire

CIMC Modular Building Systems Pioneers Sustainable Modular Hotel Construction in Saudi Arabia, Setting a New Benchmark in the Middle East

omandailynews.com
RIYADH, Saudi Arabia, June 5, 2025 /PRNewswire/ — CIMC Modular Building Systems (MBS), a global leader in modular construction, has signed a landmark agreement to deliver the Earth Hotel in Riyadh, Saudi Arabia. As the company’s first hospitality project in the region, this milestone reinforces CIMC MBS’s commitment to advancing sustainable......
news aktuell

HEIDELBERG focuses on economic efficiency in FY 2025/26 – operating margin set to rise further

omandailynews.com
Targets for financial year 2024/25 achieved – sales and adjusted EBITDA margin match previous year’s figure Significantly positive free cash flow of € 51 million China Print trade show’s positive impact on orders creates basis for good start to FY 2025/26 Areas with growth potential range from packaging and digital printing to software......
News

UAE president welcomes Egypt’s El-Sisi in Abu Dhabi

omandailynews.com
President Abdel Fattah El-Sisi of Egypt arrived in Abu Dhabi on Wednesday for a fraternal visit to the United Arab Emirates. The visit underscores the close bilateral relations between the two nations and reflects the ongoing coordination on various regional and international matters. UAE President Sheikh Mohamed bin Zayed Al Nahyan personally received President El-Sisi upon......
PR Newswire

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

omandailynews.com
LEHI, Utah, June 4, 2025 /PRNewswire/ — Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today announced the completion of enrollment for its open-label Phase 2a clinical trial evaluating HT-6184 (Ofirnoflast) in patients with lower-risk Myelodysplastic Syndrome (MDS) who are refractory to, intolerant of, or ineligible......